Treatment-free survival with first-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: a critical analysis beyond PD-L1 expression.

ABSTRACT:

SUBMITTER: Sarfraz Z 

PROVIDER: S-EPMC12876026 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature